Last Friday I wrote about why nutraceutical companies need clinical evidence. Today: how to design a study that people will actually believe.
A study's credibility is decided at the design stage. No amount of good monitoring can rescue a poorly designed trial.
1. Start with the claim
Write down the exact claim you want to make, for example "supports healthy joint mobility in adults". Every design choice should serve that claim. Studies designed to "see what happens" rarely support any claim well.
2. Choose the right population
Enrol people who match the intended consumers – for instance, healthy adults with mild symptoms rather than patients with diagnosed disease, since nutraceuticals cannot make disease claims. Clear inclusion and exclusion criteria reduce variability.
3. Pick meaningful, measurable endpoints
- Use validated tools where possible: standard questionnaires, recognised biomarkers or objective measurements.
- Define one primary endpoint that directly reflects the claim.
- Keep secondary endpoints limited and relevant.
- Avoid vague endpoints such as "overall wellbeing" without a validated scale.
4. Use a proper comparator
A randomised, double-blind, placebo-controlled design remains the most persuasive. Nutraceutical effects are often modest, and placebo effects can be large, especially for subjective outcomes. Without a placebo, it is almost impossible to show that your product, not expectation, caused the change.
Matching placebo appearance, taste and smell matters, particularly for powders, beverages and herbal extracts.
5. Justify the sample size
Too small and the study cannot detect a real effect; too large and you waste resources. Work with a statistician to calculate the sample size from the expected effect size, variability and allowance for drop-outs. Document the calculation in the protocol.
6. Choose a realistic duration
The study must be long enough for the effect to appear and, ideally, to show it is maintained. Duration should be based on the biology of the ingredient and previous evidence.
7. Plan for compliance and diet
Nutraceutical outcomes can be influenced by diet, exercise and other supplements. Record and, where needed, control these. Track product compliance with returns or diaries.
8. Register and pre-specify
Register on CTRI before enrolment and pre-specify endpoints and analysis in the protocol. This prevents any suspicion of selective reporting.
9. Run it to GCP standards
Ethics approval, proper consent, monitoring and documentation turn a promising design into trustworthy evidence.
A quick design checklist
- Claim clearly defined?
- Population matches the target consumer?
- Validated primary endpoint?
- Randomised and placebo-controlled?
- Sample size justified?
- Registered on CTRI?
- Independent monitoring planned?
Planning a nutraceutical study? I can review your protocol and provide independent monitoring. Write to me at anup.cra@gmail.com.
– Anup Kumar, Independent Clinical Research Auditor & Consultant, New Delhi